Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

AST

Asterias Biotherapeutics, Inc. (AST)

Asterias Biotherapeutics Common Series A
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:AST
일자시간출처헤드라인심볼기업
2019/03/2106:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/2019:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/2019:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/2019:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1503:55Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1503:55Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1503:53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1503:52Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1503:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1503:49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1503:48Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1306:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1305:52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/1219:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0906:07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0905:18Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0606:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0606:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0606:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0206:35Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0206:34Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/03/0107:24Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/02/0507:26Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/01/2506:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/01/2421:00GlobeNewswire Inc.Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord InjuryAMEX:ASTAsterias Biotherapeutics Common Series A
2019/01/0507:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/01/0507:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
2019/01/0422:00GlobeNewswire Inc.BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...AMEX:ASTAsterias Biotherapeutics Common Series A
2018/12/0620:22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:ASTAsterias Biotherapeutics Common Series A
2018/12/0620:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:ASTAsterias Biotherapeutics Common Series A
 검색 관련기사 보기:AMEX:AST